Nombre de los medicamentos: Genérico y Comercial – Aprenda acerca de las causas, los síntomas, el diagnóstico y el tratamiento de los Manuales MSD. Se ha demostrado que los antibióticos aplicados en el párpado alivian los síntomas y resuelven la infección bacteriana de los párpados. Contraindicadas en casos de hipersensibilidad a cualquiera de los antibióticos del grupo de la neomicina (aminoglucósidos), ya que existe sensibilización.
|Published (Last):||4 April 2009|
|PDF File Size:||15.72 Mb|
|ePub File Size:||1.72 Mb|
|Price:||Free* [*Free Regsitration Required]|
Sujetos de cualquier edad en la visita 1 Nota: Full list of Inclusion criteria can be oftqlmicos in the protocol. The majority of patients positively responded to treatment. Cancer AND drug name. Have any known clinically significant optic nerve defects. Committee on Advanced therapies CAT has issued a classification for this product.
Pneumonia AND sponsor name. Trials with results Trials without results. Tener un herpes ocular activo o antecedente. Have known or suspected intolerance or hypersensitivity to the investigational product, closely ofyalmicos compounds, or any of the stated ingredients. How to search [pdf]. Similarly, most of the anophthalmic cavities are atypical in adults with loss of eyeball from traumatism.
Full list of Exclusion criteria can be found in the protocol.
A match of Chilean pharma patents to the ISP register
Arch Soc Esp Oftalmol. Key Secondary Efficacy Endpoints: The primary objective of this study is to evaluate the efficacy of SHP based on clinical resolution defined oftalmico absence of bulbar conjunctival injection and ocular conjunctival discharge compared with placebo in the treatment of subjects with bacterial conjunctivitis in the study eye at Visit 3 Day 5.
Have a preplanned overnight hospitalization during the period of the study.
The key secondary objective of this study is to evaluate the efficacy of SHP based on bacterial eradication defined as absence of all bacterial species present at or above pathological threshold at baseline compared with placebo in the treatment of subjects with bacterial conjunctivitis in the study eye at Visit 3 Day 5. The global clinical score defined as the sum of bulbar conjunctival injection and ocular conjunctival discharge and change from baseline in the global zntibioticos score at Visits 2 Day 33 Day 54 Day 8and 5 Day 12 in the study eye 6.
Allergic oftalmixos and conjunctival retraction are the most frequent illnesses in the patients wearing ocular prosthesis for more than one year, due to Staphylococcus aureus presence resulting from frequent hygienic handling of the prosthesis. Conocimiento, capacidad y voluntad para cumplir plenamente con los antibiotocos y restricciones del estudio por los progenitores, tutor o representante legal autorizado, si procede.
Visit 3 Day 5 2. Time to clinical resolution based upon assessments at Visits 2 Day 33 Day 54 Day 8and 5 Day 12 in the study eye 9. Clinical resolution status of bacterial conjunctivitis at Visits 2 Day 34 Day 8 oftaljicos, and 5 Day 12 in the study eye 3. IMP with orphan designation in the indication.
Questionnaire of the psychosocial profile of the patient with anophthalmia with indication of ocular prosthesis. Clinical resolution status defined as absence of bulbar conjunctival injection and ocular conjunctival discharge in the study eye at Visit 3 Day 5 between SHP and placebo.
Expanded clinical resolution status, defined as a global clinical score of 0, 1, or 2 with neither injection nor discharge having a score of 2, at Visits 2 Day 33 Day 54 Day 8and 5 Day 12 in the study eye 8. Nicodemo D, Ferreira LM. The trial involves single site in the Member State concerned.
Have a clinical diagnosis of oftalimcos bacterial conjunctivitis in at least 1 eye confirmed by the presence of the following minimal clinical signs and symptoms in that same eye: Bacterial eradication status defined as absence of all bacterial species present at or above pathological threshold at baseline in the study eye at Visit 3 Day 5 between SHP and placebo.
Neonates or infants ie. Las secreciones toman por esta causa un color verde-azuloso. Definition of the end of the trial and justification where it is not the last visit of the last subject undergoing the trial. Use of rescue medication Safety Endpoints: Presence of nasolacrimal duct obstruction at Visit 1 Day 1. Le siguen, en orden de frecuencia, las infecciones y el glaucoma. Plans for treatment or care after the pftalmicos has ended the participation in the trial if it is different from the expected normal treatment of that condition.
Uso de medicamentos de rescate. Current or relevant history of physical or psychiatric illness, any medical disorder that may make the subject unlikely to fully complete the study, odtalmicos any condition that presents undue risk from the investigational product or oftalmicoa.
Clinical trials The European Union Clinical Trials Register allows you to search for protocol and results information on: Be willing to discontinue contact lens wear for the duration of the study.